Causes of PRES in Young Women with SLE
In a young woman with SLE, PRES is most commonly triggered by hypertension, lupus nephritis, high disease activity, hypomagnesemia, and very-high-dose glucocorticoid therapy 1.
Primary Causative Factors
The development of PRES in SLE patients involves multiple interconnected mechanisms:
Hypertension (Most Critical Factor)
- Hypertensive emergency is the strongest predictor (OR 38.4) of PRES development in SLE patients 1
- Often occurs in the context of acute renal dysfunction from lupus nephritis 2, 3, 4
- Blood pressure control is the cornerstone of both acute management and prevention of recurrence 3
Lupus Nephritis
- Present in the majority of SLE-PRES cases 2, 4
- Increases PRES risk 10-fold (OR 10.4) 1
- Associated with elevated creatinine, BUN, and acute renal failure requiring dialysis 3, 4
- Creates a vicious cycle: nephritis → hypertension → PRES
High SLE Disease Activity
- Active lupus flares are a major trigger 2, 5
- Characterized by elevated inflammatory markers (WBC, neutrophils, CRP) and low albumin 1
- Positive ANA and anti-dsDNA antibodies typically present 4
- Low complement levels (C3/C4) indicate active disease 3
Hypomagnesemia (Newly Identified)
- Increases PRES risk 8-fold (OR 8.4) 1
- Often overlooked but clinically significant
- Should be routinely monitored and corrected in SLE patients
Immunosuppressive Therapy
- Very-high-dose glucocorticoids increase PRES risk 14-fold (OR 14.4) 1
- Cyclophosphamide therapy is frequently implicated 2, 3, 6
- The paradox: treatment for SLE can trigger PRES while simultaneously being necessary for disease control
Additional Contributing Factors
- Hematological abnormalities: Anemia, thrombocytopenia, lymphopenia 3, 6
- Renal replacement therapy: Patients newly started on hemodialysis are at higher risk 3, 6
- Dyslipidemia 6
Critical Clinical Pitfall
The most dangerous mistake is confusing PRES with neuropsychiatric SLE (NPSLE) 3, 5, 6. While both present with neurological symptoms in SLE patients:
- PRES features: Seizures, visual impairment, vomiting are MORE common; acute confusional state is LESS common 1
- Imaging is diagnostic: MRI shows characteristic posterior (occipital, parietal) vasogenic edema, though frontal and temporal lobes may also be involved 1
- PRES is reversible with appropriate treatment (blood pressure control, addressing underlying triggers), whereas NPSLE requires different immunosuppressive approaches 7
Mortality Risk Related to Treatment
Survival rates vary dramatically by glucocorticoid dosing 1:
- Very-high-dose GC: 50% survival
- High-dose GC: 88% survival
- Low-medium-dose GC: 100% survival
This creates a treatment dilemma requiring careful balance between controlling lupus activity and avoiding PRES triggers.